OLIVOLA, ENRICA
 Distribuzione geografica
Continente #
NA - Nord America 2.214
EU - Europa 137
AS - Asia 37
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 2.392
Nazione #
US - Stati Uniti d'America 2.211
IE - Irlanda 38
SE - Svezia 25
CN - Cina 18
DE - Germania 17
IT - Italia 16
UA - Ucraina 11
GB - Regno Unito 10
IN - India 10
RU - Federazione Russa 8
FR - Francia 7
KR - Corea 5
CA - Canada 3
CL - Cile 2
EU - Europa 2
FI - Finlandia 2
AT - Austria 1
CH - Svizzera 1
HK - Hong Kong 1
JP - Giappone 1
RO - Romania 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
Totale 2.392
Città #
Wilmington 794
Houston 628
Woodbridge 316
Fairfield 80
Chandler 72
Ashburn 59
Seattle 37
Dublin 34
Cambridge 28
Ann Arbor 27
Medford 25
Lawrence 12
New York 11
Dearborn 10
Beijing 9
Rome 9
Pune 8
San Diego 8
Menlo Park 6
Jacksonville 5
London 4
Norwalk 4
Philadelphia 4
Creede 3
Milan 3
Palo Alto 3
Redwood City 3
Seoul 3
Falls Church 2
Nanjing 2
Shenzhen 2
Toronto 2
Washington 2
Changsha 1
Esslingen am Neckar 1
Etobicoke 1
Hefei 1
Kilburn 1
Kunming 1
Lausanne 1
Miami 1
Nagold 1
Nuremberg 1
Phoenix 1
Prescot 1
Saint Petersburg 1
San Francisco 1
Santa Clara 1
Shanghai 1
Southwark 1
Tokyo 1
Verona 1
Villa Castelli 1
Wuhan 1
Totale 2.236
Nome #
Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a natural population of cognitive intact Parkinson's Disease patients. 420
Catecholamine-based treatment in AD patients: expectations and delusions 360
Commentary: Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease 316
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 305
Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson’s disease 258
Low Serum 25(OH)D Levels in Parkinson ’s Disease; a Non Specific Marker of Neurodegeneration? 251
Does fatigue in Parkinson’s disease correlate with autonomic nervous system dysfunction? 242
Correction to: Continuous subcutaneous apomorphine infusion in Parkinson’s disease: causes of discontinuation and subsequent treatment strategies (Neurological Sciences, (2019), 40, 9, (1917-1923), 10.1007/s10072-019-03920-5) 117
Continuous subcutaneous apomorphine infusion in Parkinson’s disease: causes of discontinuation and subsequent treatment strategies 88
Validation of the Italian version of the PSP Quality of Life questionnaire 33
An attempt to dissect a peripheral marker based on cell pathology in Parkinson's disease 28
Effects of prismatic lenses on lateral axial dystonia in Parkinson's disease: a pilot study 21
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 18
Totale 2.457
Categoria #
all - tutte 5.482
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.482


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019140 0 0 0 0 0 0 0 0 0 0 72 68
2019/2020811 62 58 52 70 61 71 70 71 88 85 60 63
2020/2021563 68 69 70 63 62 63 68 49 12 12 25 2
2021/2022137 1 5 5 11 2 18 4 5 10 15 22 39
2022/2023173 13 22 8 16 19 35 19 14 17 0 4 6
2023/202472 13 3 7 1 13 30 1 1 1 2 0 0
Totale 2.457